Table 2 Distribution of the rheumatoid arthritis patients according to the presence of anti-MCV, anti-CCP, and IgM-RF
| Â | Anti-CCP-positive (n = 80), number (percentage) | Anti-CCP-negative (n = 76), number (percentage) | ||
|---|---|---|---|---|
| Â | Cutoff 20 U/mL | Cutoff 28 U/mL | Cutoff 20 U/mL | Cutoff 28 U/mL |
Anti-MCV | Â | Â | Â | Â |
   Positive | 75 (93.75) | 71 (88.75) | 14 (18.4) | 9 (11.8) |
   Negative | 5 (6.25) | 9 (11.25) | 62 (81.6) | 67 (88.2) |
RF+ | Â | Â | Â | Â |
   Anti-MCV+ | 65 (81.25) | 61 (76.25) | 5 (6.6) | 3 (3.9) |
   Anti-MCV- | 1 (3.75) | 5 (6.25) | 8 (10.5) | 10 (13.2) |
RF- | Â | Â | Â | Â |
   Anti-MCV+ | 10 (12.5) | 10 (12.5) | 9 (11.8) | 6 (7.9) |
   Anti-MCV- | 4 (5) | 4 (5) | 54 (71.1) | 57 (75) |